760039

544619

SUDEEPPHRM

img img img img
No Data Available

Sudeep Pharma Limited Share Price Update

SUDEEP PHARMA LIMITED is trading at ₹674.7 in today's session, down by ₹-22.39 or -3.21% from its previous close, with an intraday range of ₹673.00 – ₹704.95. Over the past six months, the stock has delivered a return of 0.00%. In the last month, it has returned -0.64%.

Sudeep Pharma Limited performance

Today’s low Today’s high
₹ 673.00 ₹ 704.95
₹ 674.70
52 week low 52 week high
₹ 524.05 ₹ 795.00
₹ 674.70
Open Price ₹ 693.05
Prev. Close ₹ 697.10
Volume (Shares) 148075.00
Total traded value ₹ 999.06
Upper Circuit ₹ 766.80
Lower Circuit ₹ 627.40
info

Investment Returns

Over 1 Month -0.64% Over 3 Months 5.59% Over 6 Months -12.84% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Sudeep Pharma Limited fundamentals


  • Market cap (Cr) 7,620.60
  • P/E Ratio (TTM) 70.83
  • Beta 1.02
  • Book Value / share 69.58
  • Return on equity 25.12%
  • EPS (TTM) 9.52
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 25.77
info icon alternate text
  • Market cap (Cr) 7,616.10
  • P/E Ratio (TTM) 70.83
  • Beta 0.83
  • Book Value / share 69.58
  • Return on equity 25.12%
  • EPS (TTM) 9.52
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 25.77
info icon alternate text

Sudeep Pharma Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 80.17
Operating Expense 55.04
Net Profit 25.77
Net Profit Margin (%) 32.14
Earnings Per Share (EPS) 2.31
EBITDA 38.50
Effective Tax Rate (%) 25.84
Particulars DEC 2025 (Values in Cr)
Revenue 90.28
Operating Expense 63.09
Net Profit 26.87
Net Profit Margin (%) 29.76
Earnings Per Share (EPS) 2.42
EBITDA 39.04
Effective Tax Rate (%) 26.65
Particulars SEP 2025 (Values in Cr)
Revenue 87.88
Operating Expense 60.81
Net Profit 29.74
Net Profit Margin (%) 33.84
Earnings Per Share (EPS) 2.67
EBITDA 43.70
Effective Tax Rate (%) 25.46
Particulars JUN 2025 (Values in Cr)
Revenue 80.17
Operating Expense 52.97
Net Profit 25.20
Net Profit Margin (%) 31.43
Earnings Per Share (EPS) 2.29
EBITDA 37.01
Effective Tax Rate (%) 25.48
Particulars MAR 2025 (Values in Cr)
Revenue 104.85
Operating Expense 62.67
Net Profit 33.14
Net Profit Margin (%) 31.60
Earnings Per Share (EPS) 3.05
EBITDA 48.57
Effective Tax Rate (%) 26.83
Particulars MAR 2026 (Values in Cr)
Revenue 338.51
Operating Expense 231.92
Net Profit 107.58
Net Profit Margin (%) 31.78
Earnings Per Share (EPS) 9.65
EBITDA 158.28
Effective Tax Rate (%) 25.85
Particulars MAR 2025 (Values in Cr)
Revenue 356.73
Operating Expense 235.70
Net Profit 95.75
Net Profit Margin (%) 26.84
Earnings Per Share (EPS) 8.82
EBITDA 140.34
Effective Tax Rate (%) 26.01
Particulars MAR 2025 (Values in Cr)
Book Value / Share 50.48
ROE % 32.76
ROCE % 35.54
Total Debt to Total Equity 0.25
EBITDA Margin 39.91
Particulars MAR 2024 (Values in Cr)
Book Value / Share 2526.42
ROE % 37.42
ROCE % 41.24
Total Debt to Total Equity 0.22
EBITDA Margin 41.06
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1159.15
ROE % 36.15
ROCE % 35.69
Total Debt to Total Equity 0.41
EBITDA Margin 21.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 810.48
ROE % 34.17
ROCE % 35.43
Total Debt to Total Equity 0.26
EBITDA Margin 22.09
Particulars MAR 2020 (Values in Cr)
Book Value / Share 574.46
ROE % 22.29
ROCE % 25.01
Total Debt to Total Equity 0.25
EBITDA Margin 23.26
Particulars MAR 2025 (Values in Cr)
Book Value / Share 44.01
ROE % 25.12
ROCE % 28.51
Total Debt to Total Equity 0.24
EBITDA Margin 39.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 2374.56
ROE % 34.32
ROCE % 38.66
Total Debt to Total Equity 0.23
EBITDA Margin 41.06
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1681.07
ROE % 33.16
ROCE % 34.81
Total Debt to Total Equity 0.35
EBITDA Margin 24.86
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1193.96
ROE % 36.81
ROCE % 36.98
Total Debt to Total Equity 0.36
EBITDA Margin 22.10
Particulars MAR 2021 (Values in Cr)
Book Value / Share 822.76
ROE % 35.54
ROCE % 36.73
Total Debt to Total Equity 0.26
EBITDA Margin 22.70
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 51.80
Total Assets 717.17
Total Liabilities 717.17
Total Equity 493.09
Share Outstanding 9
Price to Book Ratio 0.00
Return on Assets (%) 19.34
Return on Capital (%) 22.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.97
Total Assets 513.86
Total Liabilities 513.86
Total Equity 355.99
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 25.92
Return on Capital (%) 30.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 21.47
Total Assets 343.80
Total Liabilities 343.80
Total Equity 163.33
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 14.59
Return on Capital (%) 20.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.95
Total Assets 212.70
Total Liabilities 212.70
Total Equity 114.20
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 15.67
Return on Capital (%) 22.95
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 4.09
Total Assets 130.83
Total Liabilities 130.83
Total Equity 80.94
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 13.78
Return on Capital (%) 18.4
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 45.34
Total Assets 604.09
Total Liabilities 604.09
Total Equity 430.11
Share Outstanding 9
Price to Book Ratio 0.00
Return on Assets (%) 15.84
Return on Capital (%) 17.45
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.59
Total Assets 450.59
Total Liabilities 450.59
Total Equity 334.59
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 21.76
Return on Capital (%) 24.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.35
Total Assets 416.02
Total Liabilities 416.02
Total Equity 236.87
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 16.14
Return on Capital (%) 21.91
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 14.87
Total Assets 333.16
Total Liabilities 333.16
Total Equity 168.24
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 15.69
Return on Capital (%) 21.71
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 8.19
Total Assets 213.81
Total Liabilities 213.81
Total Equity 115.93
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 16.36
Return on Capital (%) 23.8
Particulars MAR 2025 (Values in Cr)
Net Income 182.84
Cash from Operations 89.27
Cash from Investing -78.75
Cash from Financing 52.69
Net change in Cash 22.66
Free Cash Flow 153.50
Particulars MAR 2024 (Values in Cr)
Net Income 174.81
Cash from Operations 110.43
Cash from Investing -49.28
Cash from Financing -12.73
Net change in Cash 3.66
Free Cash Flow 162.89
Particulars MAR 2022 (Values in Cr)
Net Income 68.60
Cash from Operations 14.59
Cash from Investing -38.41
Cash from Financing 50.91
Net change in Cash 9.51
Free Cash Flow 88.21
Particulars MAR 2021 (Values in Cr)
Net Income 43.02
Cash from Operations 45.87
Cash from Investing -40.41
Cash from Financing 12.99
Net change in Cash 7.85
Free Cash Flow 57.56
Particulars MAR 2020 (Values in Cr)
Net Income 24.60
Cash from Operations 15.91
Cash from Investing -22.47
Cash from Financing 12.44
Net change in Cash -0.15
Free Cash Flow 25.11
Particulars MAR 2025 (Values in Cr)
Net Income 129.40
Cash from Operations 88.82
Cash from Investing -91.59
Cash from Financing 54.19
Net change in Cash 21.75
Free Cash Flow 149.90
Particulars MAR 2024 (Values in Cr)
Net Income 132.30
Cash from Operations 95.27
Cash from Investing -40.66
Cash from Financing -16.14
Net change in Cash 2.24
Free Cash Flow 127.09
Particulars MAR 2023 (Values in Cr)
Net Income 90.77
Cash from Operations 64.09
Cash from Investing -40.71
Cash from Financing -10.11
Net change in Cash -8.52
Free Cash Flow 102.45
Particulars MAR 2022 (Values in Cr)
Net Income 70.40
Cash from Operations 11.73
Cash from Investing -27.96
Cash from Financing 39.97
Net change in Cash 6.67
Free Cash Flow 68.66
Particulars MAR 2021 (Values in Cr)
Net Income 44.95
Cash from Operations 46.39
Cash from Investing -44.71
Cash from Financing 12.99
Net change in Cash 4.09
Free Cash Flow 58.08
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 14.41 1.68 267.30 23.12 40.00
BLISS GVS PHARMA LTD. 396.35 32.07 3.51 4192.95 118.35 399.00
CIPLA LTD 1418.20 28.08 3.32 114562.27 1165.55 1672.20
FERMENTA BIOTECH LIMITED 293.20 12.93 2.12 862.92 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 24.39 4.49 267.30 23.12 40.00
AMRUTAJAN HEALTH LTD 559.20 25.06 4.36 1616.68 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8655.30 104.02 27.08 21638.25 7630.00 10653.05
BLISS GVS PHARMA LTD. 396.35 42.62 3.62 4192.95 118.35 399.00

Sudeep Pharma Limited shareholding pattern

Holding
4.18%
76.15%
1.55%
18.11%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Sudeep Pharma Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
674.70 -3.21 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 679.10
  • 26 Days 662.90
  • 10 Days 672.60
  • 50 Days 652.70
  • 12 Days 671.00
  • 100 Days 641.80
  • 20 Days 666.30
  • 200 Days 634.80
703.18 PIVOT
First Support 684.17 First Resistance 716.12 Second Support 671.23 Second Resistance 735.13 Third Support 652.22 Third Resistance 748.07
RSI 54.04 ADX 28.48 MACD 8.10 Williams % R -54.67 Commodity Channel Index (CCI) 44.30
Date 2026-05-27 Week 108466.00 Same Day 81933.00 Month 60101.00
1 Year 1.03 3 Year 1.03
Over 1 Month
-0.64% down
Over 1 Year
0.00% down
Over 3 Months
5.59% down
Over 3 Years
0.00% down
Over 6 Months
-12.84% down
Over 5 Years
0.00% down

Sudeep Pharma Limited Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sudeep Pharma Ltd?

Answer Field

Sudeep Pharma Ltd share price is for NSE ₹ 674.70 & for BSE ₹ 672.45 as on May 27 2026 03:30 PM.

What is the Market Cap of Sudeep Pharma Ltd Share?

Answer Field

The market cap of Sudeep Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 27 2026 03:30 PM.

What is the 52 Week High and Low of Sudeep Pharma Ltd?

Answer Field

The 52 Week High and Low of Sudeep Pharma Ltd for NSE is ₹ 795.00 and ₹ 524.05 and for BSE is ₹ 795.80 and ₹ 524.95.

What is 1 year return for Sudeep Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Sudeep Pharma Ltd Share?

Answer Field

As on May 27 2026 03:30 PM the price-to-earnings (PE) ratio for Sudeep Pharma Ltd share is 70.83.

What is the PB ratio of Sudeep Pharma Ltd Share?

Answer Field

As on May 27 2026 03:30 PM, the price-to-book (PB) ratio for Sudeep Pharma Ltd share is 69.58.

How to Buy Sudeep Pharma Ltd Share?

Answer Field

You can trade in Sudeep Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sudeep Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Sudeep Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sudeep Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|